Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D-Reference-Cited by-同舟云学术

Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D

Published:2023-02-24 Issue:2 Volume:4 Page:e225610
ISSN:2689-0186
Container-title:JAMA Health Forum
language:en
Short-container-title:JAMA Health Forum

Author:

Naci Huseyin¹,Forrest Robin¹,Zhai Mike²,Stofesky Amanda R.³,Kesselheim Aaron S.²

Affiliation:

1. Department of Health Policy, London School of Economics and Political Science, London, United Kingdom

2. Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

3. Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, New Hampshire

Abstract

This cross-sectional study examines the characteristics of prior authorization policies for new drugs in Medicare Part D to understand whether they are consistent with US Food and Drug Administration indications.

Publisher

American Medical Association (AMA)

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://jamanetwork.com/journals/jama-health-forum/articlepdf/2801780/naci_2023_ld_230004_1677008270.53424.pdf

Reference6 articles.

1. Peering into the black box: billing and insurance activities in a medical group.;Sakowski;Health Aff (Millwood),2009

2. Coverage of new drugs in Medicare Part D.;Naci;Milbank Q,2022

3. Changing the game of prior authorization: the patient perspective.;Gaines;JAMA,2020

4. Use of extrapolation in new drug approvals by the US Food and Drug Administration.;Feldman;JAMA Netw Open,2022

5. American Medical Association. 2019 AMA Prior Authorization (PA) Physician Survey. Accessed June 24, 2020. https://www.ama-assn.org/system/files/2020-06/prior-authorization-survey-2019.pdf

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Patient Experience of Prior Authorization for Cancer Care;JAMA Network Open;2023-10-18